Total Payments
$27,888
2024 Payments
$3,856
Companies
22
Transactions
191
Medicare Patients
12,839
Medicare Billing
$12.1M
Payment Breakdown by Category
Consulting$17,035 (61.1%)
Food & Beverage$6,221 (22.3%)
Other$2,679 (9.6%)
Travel$1,917 (6.9%)
Gifts$19.40 (0.1%)
Education$17.19 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,035 | 5 | 61.1% |
| Food and Beverage | $6,221 | 178 | 22.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,679 | 2 | 9.6% |
| Travel and Lodging | $1,917 | 4 | 6.9% |
| Gift | $19.40 | 1 | 0.1% |
| Education | $17.19 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $10,390 | 36 | $0 (2024) |
| Allergan, Inc. | $8,655 | 31 | $0 (2021) |
| Glaukos Corporation | $2,679 | 2 | $0 (2024) |
| Genentech, Inc. | $2,385 | 5 | $0 (2024) |
| Alcon Laboratories Inc | $795.83 | 7 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $664.16 | 21 | $0 (2024) |
| ABBVIE INC. | $459.15 | 28 | $0 (2024) |
| Alimera Sciences, Inc. | $419.63 | 16 | $0 (2024) |
| RxSight Inc | $314.52 | 1 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $282.09 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,856 | 40 | Glaukos Corporation ($2,500) |
| 2023 | $1,100 | 34 | Genentech, Inc. ($219.08) |
| 2022 | $769.48 | 34 | Bausch & Lomb Americas Inc. ($172.80) |
| 2021 | $2,710 | 32 | Genentech USA, Inc. ($2,230) |
| 2020 | $2,530 | 19 | Genentech, Inc. ($2,000) |
| 2019 | $7,849 | 14 | Genentech USA, Inc. ($7,622) |
| 2018 | $5,505 | 11 | Allergan Inc. ($4,918) |
| 2017 | $3,569 | 7 | Allergan Inc. ($3,360) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 12/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Glaukos Corporation | iStent Trabecular Micro-Bypass System Model iS3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Glaucoma | ||||||
| 12/04/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/26/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: EYE CARE | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Ophthalmology | ||||||
| 10/21/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: EYE CARE | ||||||
| 10/20/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $126.17 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/18/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $314.52 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Ophthalmology | ||||||
| 10/15/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: EYE CARE | ||||||
| 10/03/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: EYE CARE | ||||||
| 09/18/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: EYE CARE | ||||||
| 09/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: EYE CARE | ||||||
| 08/15/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: OPTOMETRY | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: EYE CARE | ||||||
| 06/25/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: EYE CARE | ||||||
| 05/20/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/17/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Ophthalmology | ||||||
| 05/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.40 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 3,286 | 65,576 | $5.4M | $3.8M |
| 2022 | 19 | 3,348 | 22,045 | $5.3M | $3.7M |
| 2021 | 25 | 3,211 | 11,504 | $3.8M | $2.6M |
| 2020 | 21 | 2,994 | 9,187 | $2.8M | $2.0M |
Total Patients
12,839
Total Services
108,312
Medicare Billing
$12.1M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 168 | 55,624 | $2.2M | $1.6M | 74.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 226 | 2,240 | $2.2M | $1.5M | 68.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 420 | 1,765 | $240,321 | $170,100 | 70.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 38 | 670 | $268,000 | $122,510 | 45.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 822 | 1,381 | $177,048 | $121,189 | 68.4% |
| 92134 | Imaging of retina | Office | 2023 | 980 | 2,838 | $119,646 | $82,972 | 69.3% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 21 | 406 | $83,230 | $64,365 | 77.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 223 | 238 | $31,450 | $21,007 | 66.8% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 21 | 21 | $24,066 | $18,929 | 78.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 150 | 150 | $20,810 | $15,551 | 74.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 109 | 109 | $18,696 | $12,590 | 67.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 86 | 110 | $10,132 | $7,135 | 70.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,057 | $576.32 | 54.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 13 | $754.00 | $496.54 | 65.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 290 | 3,038 | $3.0M | $2.2M | 72.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 98 | 1,883 | $753,200 | $424,901 | 56.4% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 59 | 9,720 | $375,678 | $290,058 | 77.2% |
| J3590 | Unclassified biologics | Office | 2022 | 42 | 117 | $341,625 | $266,093 | 77.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 412 | 1,870 | $244,233 | $177,097 | 72.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 717 | 1,155 | $147,910 | $101,578 | 68.7% |
| 92134 | Imaging of retina | Office | 2022 | 948 | 2,944 | $124,296 | $86,679 | 69.7% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 29 | 519 | $107,375 | $81,583 | 76.0% |
| 67041 | Removal of membrane of retina | Facility | 2022 | 22 | 22 | $25,466 | $19,723 | 77.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 188 | 190 | $24,760 | $18,467 | 74.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 198 | $26,272 | $18,379 | 70.0% |
About Dr. Romulo Albuquerque, MD
Dr. Romulo Albuquerque, MD is a Ophthalmology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1265726905.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Romulo Albuquerque, MD has received a total of $27,888 in payments from pharmaceutical and medical device companies, with $3,856 received in 2024. These payments were reported across 191 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($17,035).
As a Medicare-enrolled provider, Albuquerque has provided services to 12,839 Medicare beneficiaries, totaling 108,312 services with total Medicare billing of $12.1M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Uveitis and Ocular Inflammatory Disease, Student in an Organized Health Care Education/Training Program
- Location Lexington, KY
- Active Since 05/29/2011
- Last Updated 11/28/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1265726905
Products in Payments
- Lucentis (Biological) $12,050
- OZURDEX (Drug) $9,082
- iStent Trabecular Micro-Bypass System Model iS3 (Device) $2,500
- Constellation (Device) $795.83
- EYLEA (Biological) $490.04
- Vabysmo (Drug) $409.27
- ILUVIEN (Drug) $321.56
- RXSIGHT CONTACT LENS (Device) $314.52
- Izervay (Drug) $229.79
- Syfovre (Drug) $184.00
- KXL system (not refurbished) (Device) $178.50
- EYLEA HD (Biological) $174.12
- Cimerli (Biological) $156.64
- YUTIQ (Drug) $147.00
- XIPERE (Drug) $145.98
- Susvimo (Drug) $126.33
- BTOD (Device) $116.13
- SUSVIMO (Drug) $59.24
- VISUDYNE (Drug) $53.23
- IHEEZO (Drug) $33.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lexington
Dr. John Kitchens, M.d, M.D
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Dr. Jeremy Kieval, M.d, M.D
Ophthalmology — Payments: $354,855
Ophthalmology $354,855
Gary Wortz, Md, MD
Ophthalmology — Payments: $195,872
Ophthalmology $195,872
Blake Isernhagen, Md, MD
Ophthalmology — Payments: $188,723
Ophthalmology $188,723
Dr. Bruce Koffler, Md, MD
Ophthalmology — Payments: $100,236
Ophthalmology $100,236
Kunal Kanitkar, M.d, M.D
Ophthalmology — Payments: $75,249
Ophthalmology $75,249